en · de · es
lab-handbook.peptides9000.com › Topic › Chemical Identity And Research Background — Beginner to Advanced

Chemical Identity And Research Background — Beginner to Advanced

By Editorial Desk · published 2025-10-06 · last reviewed 2025-11-27 · Topic

This is a working overview of pineal peptides, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-11-27. Anything still debated is marked as such rather than presented as settled.

Chemical Identity and Research Background

In its supplied form epitalon is a white to off-white powder, usually lyophilized and often hygroscopic. It dissolves readily in water and in aqueous buffers, and it is commonly handled as the acetate or trifluoroacetate salt to improve stability during purification and drying. The amide backbone is labile in aqueous media, so solutions are less durable than the dry solid. Handling notes in the chemical literature therefore emphasize keeping the powder dry, cool and shielded from light until it is dissolved.

Epitalon is a synthetic tetrapeptide whose sequence is alanine-glutamate-aspartate-glycine, written in single-letter code as AEDG. The four residues are joined by three peptide bonds, giving a linear backbone with no branching and no disulfide bridges. Its calculated molecular mass for the free form is approximately 390.3 daltons, a figure that rises when the compound is supplied as an acetate or trifluoroacetate salt. Because the chain is short, the molecule is defined entirely by its residue order rather than by any folded three-dimensional structure.

Origin and Telomerase Research Claims

Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.

Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.

The most widely cited claim is that epitalon activates telomerase and thereby extends telomere length. Supporting evidence comes largely from cultured human cells, where treatment was associated with increased telomerase activity and delayed replicative senescence. Telomerase activation is a biologically consequential effect, since the enzyme is largely silenced in most somatic cells. However, the route by which a short peptide would reach and act on the enzyme's regulatory machinery has not been established. Independent replication in human trials is scarce, so the link between cell-culture observations and whole-body aging remains an open question.

Epitalon at a glance

PropertyValueNotes
Chemical classSynthetic tetrapeptideFour residues, linear chain
Residue sequenceAla-Glu-Asp-GlySingle-letter form AEDG
Calculated mass390.3 daltonsValue for the free, uncharged form
AppearanceWhite to off-white powderUsually supplied lyophilized
SolubilityFreely soluble in waterOften handled as a salt form

Epitalon Background and Discovery

The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.

Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.

Epitalon is a synthetic four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9, and its calculated molar mass is approximately 390.35 grams per mole. The compound is a short fragment related to a peptide fraction isolated from bovine pineal gland extracts, and it is normally supplied as a lyophilised powder intended for laboratory research. It is not a registered pharmaceutical product in most countries.

Related pages on this site

Storage, Assay, and Regulatory Framework

Regulatory treatment differs by country. No formulation of epitalon holds a marketing authorisation as a medicine in the United States or the European Union, where material sold for laboratory use is handled as a research chemical and is not intended for human consumption. In Russia, several short peptide preparations from the same institute's peptide series are registered medicinal products, and epitalon appears in that national context. Elsewhere it is frequently offered as a cosmetic ingredient, a category with lighter requirements. Advertising claims about longevity or disease prevention are restricted in most jurisdictions, which limits how sellers describe the compound.

Freeze-dried epitalon is normally kept at minus twenty degrees Celsius in a sealed, desiccated container, protected from light. Short excursions at ambient temperature during shipping are generally tolerated, but repeated warming and cooling cycles encourage moisture uptake, which shortens shelf life. Once dissolved, the peptide is far less stable than the solid: aqueous solutions are subject to hydrolysis and to deamidation at the aspartate and glutamate residues. Working solutions are therefore held refrigerated and used within days, and repeated freezing and thawing of the same vial is best avoided.

Epitalon Background and Nomenclature

The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.

Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.

Further detail

The G-spot is analogous to the base of the penis and has additionally been theorized, with the sentiment from researcher Amichai Kilchevsky that because female fetal development is the "default" state in the absence of substantial exposure to male hormones and therefore the penis is essentially a clitoris enlarged by such hormones, there is no evolutionary reason why females would have an entity in addition to the clitoris that can produce orgasms. The general difficulty of achieving orgasms vaginally, which is a predicament that is likely due to nature easing the process of childbearing by drastically reducing the number of vaginal nerve endings, challenge arguments that vaginal orgasms help encourage sexual intercourse to facilitate reproduction. Supporting a distinct G-spot, however, is a study by Rutgers University, published in 2011, which was the first to map the female genitals onto the sensory portion of the brain; the scans indicated that the brain registered distinct feelings between stimulating the clitoris, the cervix and the vaginal wall – where the G-spot is reported to be – when several women stimulated themselves in a functional magnetic resonance machine. Barry Komisaruk, head of the research findings, stated that he feels that "the bulk of the evidence shows that the G-spot is not a particular thing" and that it is "a region, it's a convergence of many different structures".

Therefore, the feedback that is read by this central regulator could include chemical and mechanical as well as cognitive cues. The significance of each of these factors will depend on the nature of the fatigue-inducing work that is being performed. Though not universally used, "metabolic fatigue" is a common alternative term for peripheral muscle weakness, because of the reduction in contractile force due to the direct or indirect effects of the reduction of substrates or accumulation of metabolites within the myocytes. This can occur through a simple lack of energy to fuel contraction, or through interference with the ability of Ca2+ to stimulate actin and myosin to contract.

Digoxin (wherein it may result in increased serum digoxin levels) Insulin or anti-diabetic medication (wherein it may enhance the effects of a hypoglycemic treatment) Drugs that prolong the QT interval such as methadone, and other arrhythmogenic drugs, as hydroxychloroquine prolongs the QT interval and may increase the risk of inducing serious abnormal heart rhythms (ventricular arrhythmias) if used concurrently. Mefloquine and other drugs known to lower the seizure threshold (co-administration with other antimalarials known to lower the convulsion threshold may increase risk of convulsions) Antiepileptics (concurrent use may impair the antiepileptic activity) Methotrexate (combined use is unstudied and may increase the frequency of side effects) Cyclosporin (wherein an increased plasma cyclosporin level was reported when used together).

=== Applications === A large area of interest in nanomedicine is the transdermal patch because of the possibility of a painless application of therapeutic agents with very few side effects. Transdermal patches have been limited to administer a small number of drugs, such as nicotine, because of the limitations in permeability of the skin. Development of techniques that increase skin permeability has led to more drugs that can be applied via transdermal patches and more options for patients. Increasing the permeability of skin allows nanoparticles to penetrate and target cancer cells. Nanoparticles along with multi-modal imaging techniques have been used as a way to diagnose cancer non-invasively. Skin with high permeability allowed quantum dots with an antibody attached to the surface for active targeting to successfully penetrate and identify cancerous tumours in mice. Tumour targeting is beneficial because the particles can be excited using fluorescence microscopy and emit light energy and heat that will destroy cancer cells.

If impaired blood flow to the heart lasts long enough, it triggers a process called the ischemic cascade; the heart cells in the territory of the blocked coronary artery die (infarction), chiefly through necrosis, and do not grow back. A collagen scar forms in their place. When an artery is blocked, cells lack oxygen, needed to produce ATP in mitochondria. ATP is required for the maintenance of electrolyte balance, particularly through the Na/K ATPase. This leads to an ischemic cascade of intracellular changes, necrosis and apoptosis of affected cells. Cells in the area with the worst blood supply, just below the inner surface of the heart (endocardium), are most susceptible to damage. Ischemia first affects this region, the subendocardial region, and tissue begins to die within 15–30 minutes of loss of blood supply. The dead tissue is surrounded by a zone of potentially reversible ischemia that progresses to become a full-thickness transmural infarct. The initial "wave" of infarction can take place over 3–4 hours. These changes are seen on gross pathology and cannot be predicted by the presence or absence of Q waves on an ECG. The position, size and extent of an infarct depends on the affected artery, totality of the blockage, duration of the blockage, the presence of collateral blood vessels, oxygen demand, and success of interventional procedures. Tissue death and myocardial scarring alter the normal conduction pathways of the heart and weaken affected areas.

Sources: en.wikipedia.org

Supporting material

=== Reunion === The Doobies did not work together for the next five years, though various members got together in different configurations for annual Christmas season performances for the patients and staff at the Stanford Children's Hospital in the Bay area. Simmons released a commercially disappointing solo album, Arcade, in April 1983. During the mid-1980s, Johnston toured U.S. clubs with a band called Border Patrol, which did not release any recordings. Hossack and (briefly) Simmons worked with the group. Around 1986, Johnston and Simmons began working on an album together (according to a 1989 interview with Simmons) but abandoned the project soon after with no known finished tracks. In 1983, Knudsen and McFee formed the band Southern Pacific and recorded four albums that found success in the country charts (former Creedence Clearwater Revival bassist Stu Cook joined the band in 1986 and former Pablo Cruise guitarist David Jenkins in 1988). Out of print for many years, Simmons' Arcade was reissued on compact disc in 2007 by specialty label Wounded Bird Records, which is also the home of Southern Pacific's and Tom Johnston's catalogs. Post-Doobies, McDonald became established as a solo artist. His voice dominated adult contemporary radio throughout the 1980s, and he experienced a renaissance of popularity in the 21st century as an interpreter of Motown classics. The reformation of the Doobie Brothers was not intentional. On a personal quest for a worthy cause and after conquering his drug addiction, Knudsen became active in the Vietnam Veterans Aid Foundation.

== Toxicity == The main pattern of toxicity seen among Russula species to date has been gastrointestinal symptoms in those with a spicy (acrid) taste when eaten raw or undercooked; many of these are red-capped species such as R. emetica, R. sardonia and R. nobilis. The Asian species Russula subnigricans has been the cause of several fatal cases of rhabdomyolysis in Japan. Several active agents have been isolated from the species, including russuphelin A and cycloprop-2-ene carboxylic acid.

=== Kaku and the knowledge economy === In Physics of the Future (2011), American physicist Michio Kaku examines the conditions for humanity to converge on a Type I planetary civilization. This convergence is based primarily on the knowledge economy. Kaku uses the Kardashev scale, but develops it by adding an additional stage: a Type IV civilization would be able to draw the energy it needs from extragalactic radiation. By studying the evolution of technologies that have changed history (paper, the integrated circuit), Kaku believes that humanity is moving toward a civilization of planetary dimensions, the "starting point" of which is the Internet. A Type I civilization consumes power on the order of thousands to millions of times our current planetary output, about 100 trillion trillion watts. It would have enough energy to manipulate the occurrence of certain natural phenomena, such as earthquakes or volcanoes, and could build cities on the oceans. We can see the beginnings of a Type I civilization in the fact that a global language is developing (English), a global communication system is emerging (the Internet), a global economic system is in the making (the establishment of the European Union), and even a globalized culture is standardizing humanity (mass media, television, rock music, and Hollywood movies).

== Terminology == The term rheumatism stems from the Late Latin rheumatismus, ultimately from Greek ῥευματίζομαι "to suffer from a flux", with rheum meaning bodily fluids, i.e., any discharge of blood or bodily fluid. Before the 17th century, the joint pain which was thought to be caused by viscous humours seeping into the joints was always referred to as gout, a word adopted in Middle English from Old French gote "a drop; the gout, rheumatism". The English term rheumatism in the current sense has been in use since the late 17th century, as it was believed that chronic joint pain was caused by excessive flow of rheum which means bodily fluids into a joint.

Sources: en.wikipedia.org

Notes from published material

These genes encode a variety of well established PIDDosome components and significant signaling proteins, including PIDD1, CRADD, CASP2, p53, and cyclin-dependent kinase inhibitor 1A (CDKN1A, often referred to as p21). They also encompass four proteins not previously associated with PIDDosome signaling: centrosomal protein 20 (CEP20, also known as FOPNL), C2 domain-containing protein 3 (C2CD3), which is involved in centriole elongation, sodium channel and clathrin linker 1 (SCLT1), and ankyrin repeat domain 26 (ANKRD26). The ability of these proteins to inhibit the proliferation of cells overexpressing PLK4 was confirmed through competition assays, underscoring their important functions in cell cycle regulation. Inadequate centrosome clustering resulted in a reduced activation of the PIDDosome, as shown by diminished CASP2 activation and lower p21 levels in RPE-1 cells with PLK4 overexpression and absent ANKRD26. Further experiments, involving both ANKRD26-competent and -deficient RPE-1 cells along with various full-length proteins, mutants lacking specific domains, and non-cleavable variants, demonstrated that PIDD1's recruitment to centrioles is mediated by the interaction between the acidic region of ANKRD26 and the UPA domain of the C-terminal part of PIDD1 (PIDD1-CC), which arises from PIDD1's autoproteolytic processing. Importantly, in the context of inducible PLK4, this interaction was critical for the activation of the PIDDosome and the resulting cell cycle arrest.

He also served as a member of the executive committee of the American Society for Testing and Materials (A.S.T.M.) Committee E-19 on Chromatography (1966–1973); as a foreign member of the executive committee of the (British) Chromatographic Society (1992–1997); and as an executive committee member of the Chromatography Subdivision of the Division of Analytical Chemistry of the American Chemical Society (A.C.S.).

Launched from LC-19 at Cape Kennedy Air Force Station, Florida, Gemini 4 was the first flight to be controlled by the new Mission Control Center at the Manned Spacecraft Center in Houston, Texas, which had to conduct three-shift operations due to the flight's long duration. The broadcast of the launch was itself historic. For the first time an international audience, from 12 European nations, could watch the lift-off on live television via the Early Bird satellite. Press interest, due to the satellite broadcast and the new center in Houston, proved to be so high that NASA had to lease buildings to accommodate the 1,100 print and broadcast journalists who requested accreditation. Flight control shifted from Cape Kennedy to Houston as soon as the vehicle cleared the launch tower. At liftoff, two roll transients caused by misalignment of the Titan first-stage engines occurred; these were quickly corrected by the autopilot. The fuel top-off umbilical failed to detach and was pulled loose when the booster had climbed about 27 feet (8.2 meters). A small oscillation in the pitch and yaw planes resulted from this. Performance of all launch vehicle systems was nearly nominal. Some modifications had been made to the guidance program on Gemini 4's booster to produce a less lofted flight trajectory and a lower altitude at booster engine cut-off (BECO) than on Gemini 3; these were generally successful despite a still somewhat lofted flight path. BECO occurred at T+152 seconds; second-stage engine cut-off (SECO) occurred at T+333 seconds.

May lead to hypoglycemia or diabetes Increased risk of PCOS Increased synthesis of VLDL (hypertriglyceridemia) Hypertension (insulin increases sodium retention by the renal tubules) Coronary Artery Disease (increased insulin damages endothelial cells) Increased risk of cardiovascular disease Weight gain and lethargy (possibly connected to an underactive thyroid) Obesity and hyperinsulinemia have some links with some types of cancer

A unique tetranuclear copper center has been found in nitrous-oxide reductase. Chemical compounds which were developed for treatment of Wilson's disease have been investigated for use in cancer therapy.

Sources: en.wikipedia.org

Frequently asked questions

Which amino acids make up epitalon?

The peptide contains four residues in the order alanine, glutamate, aspartate and glycine, abbreviated AEDG. The chain is linear and held together by three peptide bonds. Its calculated mass for the uncharged free form is about 390.3 daltons.

How does epitalon differ from epithalamin?

Epithalamin refers to a crude preparation derived from bovine pineal tissue, which contains many components. Epitalon is a single synthetic tetrapeptide identified from that material and produced by chemical synthesis. The two names are sometimes confused because early reports treated the synthetic peptide as an active fragment of the extract.

Is epitalon an approved pharmaceutical?

It has been registered for clinical use in Russia, where it is associated with a small family of short peptides. In most other jurisdictions it is not an approved medicine and is traded as a research chemical. Regulatory status varies by country and changes over time.

Who developed epitalon?

Vladimir Khavinson and colleagues at research institutes in Saint Petersburg developed and studied the peptide. Their program examined short peptides as regulators of aging and neuroendocrine function. Epitalon was one of several compounds produced by that group.

Network